Literature DB >> 10913795

Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour.

F Ferrari1, A Ottani, D Giuliani.   

Abstract

The present study investigates the effects induced by the cannabinoid agonist HU 210 (25-100 microg/kg, administered intraperitoneally [i.p.]) on the following parameters: (a) sexual behaviour of male rats, categorised on the basis of seven consecutive mating pretests as sexually active (SA) and sexually inactive (SI) and (b) sexual receptivity of ovariectomised female rats displaying hormonally induced heat. The data obtained show that HU 210, administered in acute or subchronic mode (once daily for 7 and 14 days), impaired the copulatory pattern of SA rats in a dose- and mode-dependent manner, decreasing their sexual drive, mainly as represented by an increase in mount and intromission latencies, and affecting ejaculation mechanisms (represented as a decrease in intromission frequency and increase in ejaculation latency). After subchronic treatment with the highest dose had been suspended for 2 weeks, SA males' performance was still impaired. In SI rats, acute injections of the drug (25 and 50 microg/kg, i.p.) at the higher dose increased contact latency and decreased genital exploration time towards the female. Acute HU 210 (25-100 microg/kg, i.p.) also inhibited female sexual behaviour, potently reducing lordosis quotient and lordosis intensity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913795     DOI: 10.1016/s0031-9384(00)00214-6

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  8 in total

Review 1.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

2.  Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors.

Authors:  Ana Canseco-Alba; Gabriela Rodríguez-Manzo
Journal:  Psychopharmacology (Berl)       Date:  2014-03-27       Impact factor: 4.530

3.  Circulating endocannabinoid concentrations and sexual arousal in women.

Authors:  Carolin Klein; Matthew N Hill; Sabrina C H Chang; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Sex Med       Date:  2012-03-29       Impact factor: 3.802

4.  Evaluation of sex differences in cannabinoid dependence.

Authors:  Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2014-02-12       Impact factor: 4.492

5.  Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.

Authors:  Eberhard Schlicker; Agnes Redmer; Andre Werner; Markus Kathmann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

6.  Endocannabinoid modulation of male rat sexual behavior.

Authors:  Boris B Gorzalka; Anna C Morrish; Matthew N Hill
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

7.  Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Authors:  Liana Fattore; Walter Fratta
Journal:  Front Behav Neurosci       Date:  2011-09-21       Impact factor: 3.558

8.  Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains.

Authors:  Emma Leishman; Michelle N Murphy; Michelle I Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Front Mol Neurosci       Date:  2018-11-27       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.